Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consumer Preference of Phenylephrine ER vs IR in Allergic Rhinitis
NCT00976209Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of phenylephrine in allergic rhinitis (AR), vasomotor rhinitis (VMR), nasal congestion, sponsored by Bayer. Started Aug 2009; status: completed.
02
Drugs
phenylephrine
03
Conditions
allergic rhinitis (AR)vasomotor rhinitis (VMR)nasal congestion
Beyond the preview
Go deeper on NCT00976209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976209.